TY - JOUR
T1 - Human dermal matrix scaffold augmentation for large and massive rotator cuff repairs
T2 - Preliminary clinical and MRI results at 1-year follow-up
AU - Rotini, Roberto
AU - Marinelli, Alessandro
AU - Guerra, Enrico
AU - Bettelli, Graziano
AU - Castagna, Alessandro
AU - Fini, Milena
AU - Bondioli, Elena
AU - Busacca, Maurizio
PY - 2011
Y1 - 2011
N2 - The high incidence of recurrent tendon tears after repair of massive cuff lesions is prompting the research of materials aimed at mechanically or biologically reinforcing the tendon. Among the materials studied upto now, the extracellular matrix (ECM) scaffolds of human origin have proved to be the safest and most efficient, but the current laws about grafts and transplants preclude their use in Europe. In order to overcome this condition in 2006, we started a project regarding the production of an ECM scaffold of human origin which could be implanted in Europe too. In 2009, the clinical study began with the implantation of dermal matrix scaffolds in 7 middle-aged patients affected with large/massive cuff lesions and tendon degeneration. Out of 5 cases, followed for at least 1 year in which the scaffold was employed as an augmentation device, there were 3 patients with complete healing, 1 partial re-tear, and 1 total recurrence. The absence of adverse inflammatory or septic complications allows to continue this line of research with a prospective controlled study in order to define the real advantages and correct indications offered by scaffold application.
AB - The high incidence of recurrent tendon tears after repair of massive cuff lesions is prompting the research of materials aimed at mechanically or biologically reinforcing the tendon. Among the materials studied upto now, the extracellular matrix (ECM) scaffolds of human origin have proved to be the safest and most efficient, but the current laws about grafts and transplants preclude their use in Europe. In order to overcome this condition in 2006, we started a project regarding the production of an ECM scaffold of human origin which could be implanted in Europe too. In 2009, the clinical study began with the implantation of dermal matrix scaffolds in 7 middle-aged patients affected with large/massive cuff lesions and tendon degeneration. Out of 5 cases, followed for at least 1 year in which the scaffold was employed as an augmentation device, there were 3 patients with complete healing, 1 partial re-tear, and 1 total recurrence. The absence of adverse inflammatory or septic complications allows to continue this line of research with a prospective controlled study in order to define the real advantages and correct indications offered by scaffold application.
KW - Augmentation
KW - Rotator cuff
KW - Scaffold
KW - Tendon
UR - http://www.scopus.com/inward/record.url?scp=84555178483&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84555178483&partnerID=8YFLogxK
U2 - 10.1007/s12306-011-0141-8
DO - 10.1007/s12306-011-0141-8
M3 - Article
C2 - 21691735
AN - SCOPUS:84555178483
SN - 2035-5106
VL - 95
JO - Musculoskeletal Surgery
JF - Musculoskeletal Surgery
IS - SUPP
ER -